Patent GB-1036694-A (GB)
Title: Substituted aminocarboxylic acid derivatives and compositions containing such derivatives
Inventor: CROOK LEONARD ROBERT
IPC: C07D451/10
Filed: 1964-03-03
Abstract: The invention comprises (i) compounds of formula <FORM:1036694/C2/1> wherein R1 and R2 represent the atoms required to complete a 5- or 6-membered ring containing two -CO- groups, two -CH2- groups or a -CO- and -SO2- grouping adjacent to the nitrogen atom shown, said ring being fused to at least one other ring, R3, R4 and R5 are hydrogen atoms or C1- 10 alkyl or aryl groups, n is 0 or 1, R6 is an alkyl, alkenyl, dialkylaminoalkyl, aryl, substituted aryl or aminocarbonyl radical and R7 is a hydrogen atom or an alkyl, alkenyl or dialkylaminoalkyl radical, or R6 and R7 together represent the atoms required to complete a morpholino- or piperidino ring, and the grouping <FORM:1036694/C2/2> is an alkylene or alkenylene group, the free valencies of which are satisfied by hydrogen atoms, and, where appropriate, non-toxic acid addition salts thereof, and (ii) compounds of formula <FORM:1036694/C2/3> wherein the radicals R1 and R2 either represent a phthalylglycyl radical or the atoms required to complete a 5- or 6-membered ring containing two -CO- groups, two -CH2- groups or a -CO- and an -SO2- or a -CO- and a = CH- grouping adjacent to the nitrogen atom shown, said ring being fused to at least one other ring, R3 and R4 are hydrogen atoms or C1- 10 alkyl or aryl groups, n = 0 or 1, R8 is a unsubstituted or halo- or nitro-substituted aralkyl radical or an alkyl, alkenyl or tropyl radical, and the grouping <FORM:1036694/C2/4> is an alkylene or alkenylene group, the free valencies of which are satisfied by hydrogen atoms, with the proviso that when the group -NR1R2 is an unsubstituted phthalimido or 3-(3,4-dihydro-quinazolonyl) radical the whole molecule contains at least 15 carbon atoms, and, where appropriate, non-toxic acid addition salts thereof, and their preparation by (a) amide formation from the appropriate acid or reactive acid derivative, (b) esterification, (c) reaction of a cyclic imide or an alkali metal salt thereof with a haloalkanoic acid ester or amide in the presence of a strong base, (d) formation of the -NR1R2 group by reaction of an aminoalkanoic acid ester or amide to form a cyclic imide, (e) reduction of a nitro substituent to an amino-substituent, optionally with simultaneous acylation or dialkylation, (f) C-alkylation of a homophthalic acid derivative or (g) hydrolysis of a nitrile.  Carboxylic acids corresponding to the above amides and esters are prepared by (a) acylation of an aminoacid to form a cyclic imide or a phthalylglycyl derivative, (b) reaction of a cyclic imide or an alkali metal salt thereof with a haloacid or an acid lactone, or (c) reduction of a nitro-substituent to an amino-substituent.  Carboxylic acid chlorides corresponding to the above acids are obtained by treatment of the acids with thionyl chloride.  Carboxylic acid amides of the first formula above, wherein R6 and R7 are hydrogen atoms, are prepared by (a) reaction of an acid or acid derivative with ammonia or (b) hydrolysis of a nitrile. N-(31-Cyanopropyl)-derivatives of 1,2,3,4-tetrahydro - 2,4 - dioxo - quinazoline, 3,4 - dihydro-4-quinazolone, 1,1 - dioxo - 4,5 - benzisothiazolin-3-one, 3 - aminophthalimide, tetrachlorophthalimide, 1,8 - naphthalimide and 3,6 - di - (chloro-or methoxy-) phthalimide are prepared by reaction of the corresponding N-unsubstituted compounds with 3-bromobutyronitrile.  1,4 - Methano - 1,2,3,4 - tetrahydronaphthalene-2,3-dicarboxylic acid imide is prepared by reaction of the acid anhydride with ammonia.  3,6 - Diethoxy - phthalic anhydride is prepared by reaction of 3,6-dihydroxyphthalonitrile with diethyl sulphate to form 3,6-diethoxyphthalonitrile, and treating this with sodium hydroxide and hydrochloric acid.  4-Bromo-derivatives of pent-2-enoic acid, hex-2-enoic acid and 3-methyl-but-2-enoic acid are prepared by bromination with N-bromo-succinimide and benzoyl peroxide.  4 - Methyl - 4 - phthalimido - valeric acid is prepared by ammoniation of b ,b -dimethylacrylic acid to form 3-amino-3-methylbutyric acid, reacting this with phthalic anhydride to form 3 - methyl - 3 - phthalimido - butyric acid, converting this to its acid chloride, reacting this with diazomethane to form 1-diazo-4-methyl-4-phthalimido-butan-2-one, and treating this with sodium thiosulphate and silver oxide.  4 - Trifluoroacetamido - butyramide is prepared by heating trifluoroacetic acid with 3-aminobutyronitrile.  4-Amino derivatives of valeric acid, hexanoic acid and 3-methyl-butyric acid are prepared by (a) hydrogenation of an alkyl-4-nitro-acid ester or (b) treatment of levulinic acid with ammonia and hydrogen to form an alkyl-2-pyrrolidone, and splitting this lactam by treatment with barium hydroxide or an ion-exchange resin.  Methyl - 4- nitrovalerate and methyl - 4 - methyl - 4 - nitrovalerate are prepared by reaction of methyl acrylate and, respectively, nitro-ethane and 2-nitro-propane.  N,N - Dimethyl - 4 - chloro - butyramide and valeramide are prepared by reaction of the appropriate acid chloride with dimethylamine.  5-Amino-valeric acid is prepared by hydrolysis of 2-piperidone with barium hydroxide.  4 - Amino - 4 - methyl - valeric acid dimethyl-and diethyl-amides are prepared by conversion of 4-methyl-4-nitro-valeric acid to its acid chloride, reacting this with dimethylamine or diethylamine to form the 4-nitro-dimethylamide or diethylamide, and reducing the nitro-group.ALSO:Pharmaceutical compositions having hypnotic, sedative, muscle-relaxant, anti-convulsant and sedative-potentiating activity comprise, in combination with a carrier, a compound of formula <FORM:1036694/A5-A6/1> wherein R1 is a hydrogen atom and R2 is a phenyl, trifluoroacetyl or phthalimidoacetyl radial or R1 and R2 represent the atoms necessary to complete a 5- or 6-membered ring containing two -CO-groups, two -CH2- groups, or a -CO- and -SO2- or -CO- and =CH- grouping adjacent to the nitrogen atom shown, said ring being fused to at least one other ring, R3, R4 and R5 are hydrogen atoms or C1-10 alkyl or aryl groups, n is 0 or 1, the group -COX is a carboxylic acid group or a non-toxic salt, ester or optionally mono- or di-substituted amide thereof, and the grouping <FORM:1036694/A5-A6/2> is an alkylene or alkenylene group, the free valencies being satisfied by hydrogen atoms, or, when the molecule contains a salt-forming nitrogen atom, a salt thereof with a pharmaceutically acceptable acid.  The compositions may be in forms suitable for oral, parenteral or rectal administration.